# The Laparotomy Study

> **NCT02140593** · PHASE4 · COMPLETED · sponsor: **Herlev Hospital** · enrollment: 128 (actual)

## Conditions studied

- Gastrointestinal Cancer

## Interventions

- **DRUG:** Group STANDARD: Rocuronium 0.6 mg/kg followed by bolus rocuronium according to standard treatment combined with saline infusion (placebo).
- **DRUG:** Group DEEP: Rocuronium 0.6 mg/kg followed by rocuronium infusion with target level PTC 0-1 combined with bolus saline (placebo) mimicking standard treatment.

## Key facts

- **NCT ID:** NCT02140593
- **Lead sponsor:** Herlev Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-05
- **Final completion:** 2016-06
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2017-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02140593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02140593, "The Laparotomy Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02140593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*